GSKpro for UK healthcare professionals
Ordering and delivery
Ellipta critical error studies in COPD
XEVUDY ▼ (sotrovimab)
Coming soon | GSKpro
JEMPERLI ▼ (Dostarlimab (FOR NI HCP’s ONLY))
JEMPERLI ▼ (Dostarlimab (FOR GB HCP’s ONLY))
GSKpro Home | SHINGRIX
GSKpro Impact of Shingles | SHINGRIX
GSKpro Efficacy | SHINGRIX
GSKpro Safety | SHINGRIX
GSKpro SHINGRIX overview | SHINGRIX
Immunocompromised | SHINGRIX
Immunocompromised Clinical Data | SHINGRIX
Therapy areas | GSKpro UK
Discontinued products | GSK Pro
DECTOVA▼
Therapy areas | GSKpro UK
Report a possible side effect | GSKpro
Contact | GSKpro UK
Request a contact
This summer, how can GSK help you deliver the non-seasonal shingles National Immunisation Programme?
AREXVY▼
GSKpro Implementation | SHINGRIX (Herpes Zoster vaccine recombinant, adjuvanted)
Webinars & events | GSKpro
GSKpro Arexvy ▼ | Product Information for Healthcare Professionals
Respiratory
Vaccines
Products | GSKpro
ZEJULA
OMJJARA▼
FLIXOTIDE
VENTOLIN
Resources | GSKpro
Webinars & events | GSKpro
Supply
No results. Why not try:
- Checking the spelling of the search term
- Trying a different search term
- Resetting or revising the filter settings (if you used filters to do this search)
Show more
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441.